241 related articles for article (PubMed ID: 30907207)
1. Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study.
Strijker M; Belkouz A; van der Geest LG; van Gulik TM; van Hooft JE; de Meijer VE; Haj Mohammad N; de Reuver PR; Verheij J; de Vos-Geelen J; Wilmink JW; Groot Koerkamp B; Klümpen HJ; Besselink MG;
Acta Oncol; 2019 Jul; 58(7):1048-1055. PubMed ID: 30907207
[No Abstract] [Full Text] [Related]
2. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
[TBL] [Abstract][Full Text] [Related]
3. The prognostic importance of lymphovascular invasion in cholangiocarcinoma above the cystic duct: a new selection criterion for adjuvant therapy?
Patel SH; Kooby DA; Staley CA; Sarmiento JM; Maithel SK
HPB (Oxford); 2011 Sep; 13(9):605-11. PubMed ID: 21843260
[TBL] [Abstract][Full Text] [Related]
4. Impact of adjuvant chemotherapy after pancreaticoduodenectomy for distal cholangiocarcinoma: a propensity score analysis from a French multicentric cohort.
Bergeat D; Turrini O; Courtin-Tanguy L; Truant S; Darnis B; Delpero JR; Mabrut JY; Regenet N; Sulpice L
Langenbecks Arch Surg; 2018 Sep; 403(6):701-709. PubMed ID: 30112638
[TBL] [Abstract][Full Text] [Related]
5. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
[TBL] [Abstract][Full Text] [Related]
6. The short- and long-term outcomes of pancreaticoduodenectomy for distal cholangiocarcinoma.
Skalicky P; Urban O; Ehrmann J; Svebisova H; Klos D; Tesarikova J; Neoral C; Knapkova K; Lovecek M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Dec; 166(4):386-392. PubMed ID: 34467956
[TBL] [Abstract][Full Text] [Related]
7. Identification of risk and prognostic factors for patients with clonorchiasis-associated intrahepatic cholangiocarcinoma.
Zhang GW; Lin JH; Qian JP; Zhou J
Ann Surg Oncol; 2014 Oct; 21(11):3628-37. PubMed ID: 24781504
[TBL] [Abstract][Full Text] [Related]
8. Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy.
Kelley ST; Bloomston M; Serafini F; Carey LC; Karl RC; Zervos E; Goldin S; Rosemurgy P; Rosemurgy AS
Am Surg; 2004 Sep; 70(9):743-8; discussion 748-9. PubMed ID: 15481288
[TBL] [Abstract][Full Text] [Related]
9. Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium.
Lopez-Aguiar AG; Ethun CG; Pawlik TM; Tran T; Poultsides GA; Isom CA; Idrees K; Krasnick BA; Fields RC; Salem A; Weber SM; Martin RCG; Scoggins CR; Shen P; Mogal HD; Beal EW; Schmidt C; Shenoy R; Hatzaras I; Maithel SK
Ann Surg Oncol; 2019 Jun; 26(6):1814-1823. PubMed ID: 30877497
[TBL] [Abstract][Full Text] [Related]
10. Impact of adjuvant chemotherapy on survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis.
Reames BN; Bagante F; Ejaz A; Spolverato G; Ruzzenente A; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Pawlik TM
HPB (Oxford); 2017 Oct; 19(10):901-909. PubMed ID: 28728891
[TBL] [Abstract][Full Text] [Related]
11. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis.
Ecker BL; Vining CC; Roses RE; Maggino L; Lee MK; Drebin JA; Fraker DL; Vollmer CM; Datta J
Ann Surg Oncol; 2017 Dec; 24(13):3926-3933. PubMed ID: 28952140
[TBL] [Abstract][Full Text] [Related]
12. Analysis of intrahepatic sarcomatoid cholangiocarcinoma: Experience from 11 cases within 17 years.
Kim DK; Kim BR; Jeong JS; Baek YH
World J Gastroenterol; 2019 Feb; 25(5):608-621. PubMed ID: 30774275
[TBL] [Abstract][Full Text] [Related]
13. Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience.
Scheuermann U; Kaths JM; Heise M; Pitton MB; Weinmann A; Hoppe-Lotichius M; Otto G
Eur J Surg Oncol; 2013 Jun; 39(6):593-600. PubMed ID: 23611755
[TBL] [Abstract][Full Text] [Related]
14. The true prognosis of resected distal cholangiocarcinoma.
Courtin-Tanguy L; Rayar M; Bergeat D; Merdrignac A; Harnoy Y; Boudjema K; Meunier B; Sulpice L
J Surg Oncol; 2016 Apr; 113(5):575-80. PubMed ID: 26776934
[TBL] [Abstract][Full Text] [Related]
15. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR
Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
[TBL] [Abstract][Full Text] [Related]
16. It is the lymph node ratio that determines survival and recurrence patterns in resected distal cholangiocarcinoma. A multicenter international study.
Di Martino M; Koh YX; Syn N; Min Chin K; Fernando Burdió ; Sánchez Velázquez P; Manzoni A; Benedetti Cacciaguerra A; Prieto M; Lancellotti F; Malleo G; Marchegiani G; Salvia R; Vennarecci G; Abu Hilal M; Ielpo B
Eur J Surg Oncol; 2022 Jul; 48(7):1576-1584. PubMed ID: 35193776
[TBL] [Abstract][Full Text] [Related]
17. Survival improvement and prognostic factors in recent management of extrahepatic cholangiocarcinoma: A single-center study.
Choe JW; Kim HJ; Kim JS
Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):153-156. PubMed ID: 31974040
[TBL] [Abstract][Full Text] [Related]
18. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach.
Paik WH; Park YS; Hwang JH; Lee SH; Yoon CJ; Kang SG; Lee JK; Ryu JK; Kim YT; Yoon YB
Gastrointest Endosc; 2009 Jan; 69(1):55-62. PubMed ID: 18657806
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma.
Miura JT; Johnston FM; Tsai S; George B; Thomas J; Eastwood D; Banerjee A; Christians KK; Turaga KK; Pawlik TM; Clark Gamblin T
Ann Surg Oncol; 2015 Oct; 22(11):3716-23. PubMed ID: 25777092
[TBL] [Abstract][Full Text] [Related]
20. Regional disparities affect treatment and survival of patients with intrahepatic cholangiocarcinoma--a Texas Cancer Registry analysis.
Kneuertz PJ; Kao LS; Ko TC; Wray CJ
J Surg Oncol; 2014 Sep; 110(4):416-21. PubMed ID: 24889699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
